Artificial platelets that help with clot formation have been created in the past, but they’ve been limited in their ability to gather around the site where the coagulation cascade is taking place. Instead they tend to begin promoting the clotting process randomly, potentially creating dangerous blood clots. Moreover, these artificial platelets don’t contract the clot like naturally occurring ones do, probably because of their rigid nature. Now researchers at Georgia Tech and Chapman University in California have developed platelet-like particles (PLPs) that seem to overcome previous limitations, being able to move toward sites where clotting is occurring and contracting the clots much like natural platelets do.
Massachusetts General Hospital (MGH) researchers have taken some initial steps toward the creation of bioengineered human hearts using donor hearts stripped of components that would generate an immune response and cardiac muscle cells generated from […]
Jason Ayres, a family doctor in Alabama, was speechless as he held his adopted son Patrick’s heart in his hands. Well, a replica of his son’s heart — an exact replica, 3-D printed before the […]
Virtual reality technology, over recent years, has improved in leaps and bounds. Technical difficulties and a prohibitively high price tag have kept it largely under the radar in terms of usable technology, but the tide […]